Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients
1 Ansichten
• 07/14/23
0
0
Einbetten
administrator
Abonnenten
Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare